nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—ADRA1D—polycystic ovary syndrome	0.309	0.412	CbGaD
Amitriptyline—ADRA1B—polycystic ovary syndrome	0.264	0.352	CbGaD
Amitriptyline—ADRA1A—polycystic ovary syndrome	0.178	0.237	CbGaD
Amitriptyline—CYP2C19—urine—polycystic ovary syndrome	0.00194	0.0357	CbGeAlD
Amitriptyline—NTRK2—adipose tissue—polycystic ovary syndrome	0.00186	0.0342	CbGeAlD
Amitriptyline—NTRK2—adrenal gland—polycystic ovary syndrome	0.00167	0.0307	CbGeAlD
Amitriptyline—CYP1A2—urine—polycystic ovary syndrome	0.00159	0.0292	CbGeAlD
Amitriptyline—NTRK2—female gonad—polycystic ovary syndrome	0.00155	0.0286	CbGeAlD
Amitriptyline—CYP2C9—urine—polycystic ovary syndrome	0.00151	0.0277	CbGeAlD
Amitriptyline—NTRK2—endocrine gland—polycystic ovary syndrome	0.00144	0.0266	CbGeAlD
Amitriptyline—CYP2E1—urine—polycystic ovary syndrome	0.00143	0.0263	CbGeAlD
Amitriptyline—KCNQ2—pituitary gland—polycystic ovary syndrome	0.0013	0.0239	CbGeAlD
Amitriptyline—HTR2A—urine—polycystic ovary syndrome	0.00124	0.0228	CbGeAlD
Amitriptyline—KCND2—pituitary gland—polycystic ovary syndrome	0.00123	0.0227	CbGeAlD
Amitriptyline—KCND2—adipose tissue—polycystic ovary syndrome	0.00123	0.0226	CbGeAlD
Amitriptyline—CYP3A4—urine—polycystic ovary syndrome	0.00115	0.0211	CbGeAlD
Amitriptyline—CYP2D6—urine—polycystic ovary syndrome	0.00113	0.0208	CbGeAlD
Amitriptyline—KCND3—uterus—polycystic ovary syndrome	0.00109	0.0201	CbGeAlD
Amitriptyline—KCNQ2—female gonad—polycystic ovary syndrome	0.00108	0.0199	CbGeAlD
Amitriptyline—KCND3—adipose tissue—polycystic ovary syndrome	0.00107	0.0197	CbGeAlD
Amitriptyline—KCND2—female gonad—polycystic ovary syndrome	0.00103	0.0189	CbGeAlD
Amitriptyline—KCNQ2—endocrine gland—polycystic ovary syndrome	0.00101	0.0186	CbGeAlD
Amitriptyline—KCND3—adrenal gland—polycystic ovary syndrome	0.000959	0.0177	CbGeAlD
Amitriptyline—HRH2—adrenal gland—polycystic ovary syndrome	0.000748	0.0138	CbGeAlD
Amitriptyline—ORM1—endometrium—polycystic ovary syndrome	0.00065	0.012	CbGeAlD
Amitriptyline—HRH2—endocrine gland—polycystic ovary syndrome	0.000648	0.0119	CbGeAlD
Amitriptyline—SIGMAR1—adrenal cortex—polycystic ovary syndrome	0.000616	0.0113	CbGeAlD
Amitriptyline—ADRA1D—endocrine gland—polycystic ovary syndrome	0.000554	0.0102	CbGeAlD
Amitriptyline—SIGMAR1—endometrium—polycystic ovary syndrome	0.00055	0.0101	CbGeAlD
Amitriptyline—SIGMAR1—uterus—polycystic ovary syndrome	0.000507	0.00934	CbGeAlD
Amitriptyline—SIGMAR1—pituitary gland—polycystic ovary syndrome	0.000498	0.00917	CbGeAlD
Amitriptyline—SIGMAR1—adipose tissue—polycystic ovary syndrome	0.000496	0.00913	CbGeAlD
Amitriptyline—OPRM1—endocrine gland—polycystic ovary syndrome	0.000467	0.0086	CbGeAlD
Amitriptyline—ALB—adrenal gland—polycystic ovary syndrome	0.000461	0.00849	CbGeAlD
Amitriptyline—ORM1—endocrine gland—polycystic ovary syndrome	0.000456	0.0084	CbGeAlD
Amitriptyline—CHRM3—adipose tissue—polycystic ovary syndrome	0.000445	0.0082	CbGeAlD
Amitriptyline—SIGMAR1—adrenal gland—polycystic ovary syndrome	0.000445	0.00819	CbGeAlD
Amitriptyline—Epinastine—ADRA1A—polycystic ovary syndrome	0.000435	0.0966	CrCbGaD
Amitriptyline—HTR1B—endocrine gland—polycystic ovary syndrome	0.000427	0.00787	CbGeAlD
Amitriptyline—CHRM2—endocrine gland—polycystic ovary syndrome	0.000425	0.00783	CbGeAlD
Amitriptyline—SIGMAR1—female gonad—polycystic ovary syndrome	0.000415	0.00764	CbGeAlD
Amitriptyline—SIGMAR1—vagina—polycystic ovary syndrome	0.000412	0.00759	CbGeAlD
Amitriptyline—ADRA1A—adipose tissue—polycystic ovary syndrome	0.000409	0.00753	CbGeAlD
Amitriptyline—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.000403	0.00741	CbGeAlD
Amitriptyline—DRD2—pituitary gland—polycystic ovary syndrome	0.000402	0.00741	CbGeAlD
Amitriptyline—CYP2C8—endometrium—polycystic ovary syndrome	0.000401	0.00738	CbGeAlD
Amitriptyline—HTR2A—embryo—polycystic ovary syndrome	0.000401	0.00738	CbGeAlD
Amitriptyline—HTR1A—adrenal gland—polycystic ovary syndrome	0.000398	0.00732	CbGeAlD
Amitriptyline—SLC6A2—adrenal gland—polycystic ovary syndrome	0.000394	0.00726	CbGeAlD
Amitriptyline—Nortriptyline—ADRA1D—polycystic ovary syndrome	0.000391	0.087	CrCbGaD
Amitriptyline—SLC6A4—endocrine gland—polycystic ovary syndrome	0.000389	0.00715	CbGeAlD
Amitriptyline—CHRM1—endocrine gland—polycystic ovary syndrome	0.000387	0.00713	CbGeAlD
Amitriptyline—HTR7—adrenal gland—polycystic ovary syndrome	0.00038	0.007	CbGeAlD
Amitriptyline—CHRM3—female gonad—polycystic ovary syndrome	0.000372	0.00686	CbGeAlD
Amitriptyline—ADRA1A—adrenal gland—polycystic ovary syndrome	0.000367	0.00675	CbGeAlD
Amitriptyline—CYP2C8—pituitary gland—polycystic ovary syndrome	0.000363	0.00668	CbGeAlD
Amitriptyline—Doxepin—ADRA1D—polycystic ovary syndrome	0.000351	0.0781	CrCbGaD
Amitriptyline—HRH1—endometrium—polycystic ovary syndrome	0.000351	0.00647	CbGeAlD
Amitriptyline—CHRM3—endocrine gland—polycystic ovary syndrome	0.000346	0.00638	CbGeAlD
Amitriptyline—HTR1A—endocrine gland—polycystic ovary syndrome	0.000345	0.00635	CbGeAlD
Amitriptyline—ADRA2A—endometrium—polycystic ovary syndrome	0.000345	0.00635	CbGeAlD
Amitriptyline—CYP2C19—vagina—polycystic ovary syndrome	0.000344	0.00633	CbGeAlD
Amitriptyline—SLC6A2—endocrine gland—polycystic ovary syndrome	0.000342	0.0063	CbGeAlD
Amitriptyline—Nortriptyline—ADRA1B—polycystic ovary syndrome	0.000334	0.0742	CrCbGaD
Amitriptyline—HTR7—endocrine gland—polycystic ovary syndrome	0.00033	0.00607	CbGeAlD
Amitriptyline—CYP3A5—adipose tissue—polycystic ovary syndrome	0.000326	0.006	CbGeAlD
Amitriptyline—CYP2C19—endocrine gland—polycystic ovary syndrome	0.000322	0.00593	CbGeAlD
Amitriptyline—ADRA1A—endocrine gland—polycystic ovary syndrome	0.000318	0.00585	CbGeAlD
Amitriptyline—ADRA2A—uterus—polycystic ovary syndrome	0.000318	0.00585	CbGeAlD
Amitriptyline—HRH1—adipose tissue—polycystic ovary syndrome	0.000316	0.00583	CbGeAlD
Amitriptyline—Trimipramine—ADRA1B—polycystic ovary syndrome	0.000314	0.0699	CrCbGaD
Amitriptyline—Promazine—ADRA1D—polycystic ovary syndrome	0.000312	0.0694	CrCbGaD
Amitriptyline—ADRA2A—pituitary gland—polycystic ovary syndrome	0.000312	0.00575	CbGeAlD
Amitriptyline—DRD2—endocrine gland—polycystic ovary syndrome	0.000312	0.00574	CbGeAlD
Amitriptyline—ADRA2A—adipose tissue—polycystic ovary syndrome	0.000311	0.00572	CbGeAlD
Amitriptyline—CYP2C8—vagina—polycystic ovary syndrome	0.0003	0.00553	CbGeAlD
Amitriptyline—Doxepin—ADRA1B—polycystic ovary syndrome	0.0003	0.0666	CrCbGaD
Amitriptyline—CYP2B6—adrenal gland—polycystic ovary syndrome	0.000291	0.00535	CbGeAlD
Amitriptyline—HRH1—adrenal gland—polycystic ovary syndrome	0.000284	0.00523	CbGeAlD
Amitriptyline—CYP2C8—endocrine gland—polycystic ovary syndrome	0.000281	0.00517	CbGeAlD
Amitriptyline—ADRA2A—adrenal gland—polycystic ovary syndrome	0.000279	0.00513	CbGeAlD
Amitriptyline—Imipramine—ADRA1D—polycystic ovary syndrome	0.000273	0.0607	CrCbGaD
Amitriptyline—CYP2E1—adrenal gland—polycystic ovary syndrome	0.000273	0.00502	CbGeAlD
Amitriptyline—CYP3A5—female gonad—polycystic ovary syndrome	0.000273	0.00502	CbGeAlD
Amitriptyline—CYP3A5—vagina—polycystic ovary syndrome	0.000271	0.00499	CbGeAlD
Amitriptyline—CYP2B6—vagina—polycystic ovary syndrome	0.000269	0.00496	CbGeAlD
Amitriptyline—Promazine—ADRA1B—polycystic ovary syndrome	0.000266	0.0592	CrCbGaD
Amitriptyline—HTR2A—pituitary gland—polycystic ovary syndrome	0.000265	0.00489	CbGeAlD
Amitriptyline—HRH1—female gonad—polycystic ovary syndrome	0.000265	0.00487	CbGeAlD
Amitriptyline—HRH1—vagina—polycystic ovary syndrome	0.000263	0.00484	CbGeAlD
Amitriptyline—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000263	0.00484	CbGeAlD
Amitriptyline—ABCB1—embryo—polycystic ovary syndrome	0.000263	0.00484	CbGeAlD
Amitriptyline—ADRA2A—female gonad—polycystic ovary syndrome	0.00026	0.00479	CbGeAlD
Amitriptyline—ADRA2A—vagina—polycystic ovary syndrome	0.000258	0.00476	CbGeAlD
Amitriptyline—CYP3A5—endocrine gland—polycystic ovary syndrome	0.000254	0.00467	CbGeAlD
Amitriptyline—CYP2B6—endocrine gland—polycystic ovary syndrome	0.000252	0.00464	CbGeAlD
Amitriptyline—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00025	0.0046	CbGeAlD
Amitriptyline—HRH1—endocrine gland—polycystic ovary syndrome	0.000246	0.00453	CbGeAlD
Amitriptyline—ADRA2A—endocrine gland—polycystic ovary syndrome	0.000242	0.00445	CbGeAlD
Amitriptyline—HTR2A—adrenal gland—polycystic ovary syndrome	0.000237	0.00437	CbGeAlD
Amitriptyline—CYP2E1—endocrine gland—polycystic ovary syndrome	0.000237	0.00436	CbGeAlD
Amitriptyline—Imipramine—ADRA1B—polycystic ovary syndrome	0.000233	0.0518	CrCbGaD
Amitriptyline—Nortriptyline—ADRA1A—polycystic ovary syndrome	0.000225	0.05	CrCbGaD
Amitriptyline—HTR2A—vagina—polycystic ovary syndrome	0.00022	0.00405	CbGeAlD
Amitriptyline—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000215	0.00396	CbGeAlD
Amitriptyline—Trimipramine—ADRA1A—polycystic ovary syndrome	0.000212	0.047	CrCbGaD
Amitriptyline—HTR2A—endocrine gland—polycystic ovary syndrome	0.000206	0.00379	CbGeAlD
Amitriptyline—Promethazine—ADRA1A—polycystic ovary syndrome	0.000204	0.0453	CrCbGaD
Amitriptyline—Doxepin—ADRA1A—polycystic ovary syndrome	0.000202	0.0448	CrCbGaD
Amitriptyline—CYP2D6—female gonad—polycystic ovary syndrome	0.000201	0.00371	CbGeAlD
Amitriptyline—ABCB1—endometrium—polycystic ovary syndrome	0.000192	0.00354	CbGeAlD
Amitriptyline—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00019	0.0035	CbGeAlD
Amitriptyline—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000187	0.00345	CbGeAlD
Amitriptyline—Promazine—ADRA1A—polycystic ovary syndrome	0.000179	0.0399	CrCbGaD
Amitriptyline—ABCB1—uterus—polycystic ovary syndrome	0.000177	0.00326	CbGeAlD
Amitriptyline—ABCB1—pituitary gland—polycystic ovary syndrome	0.000174	0.0032	CbGeAlD
Amitriptyline—ABCB1—adipose tissue—polycystic ovary syndrome	0.000173	0.00319	CbGeAlD
Amitriptyline—Imipramine—ADRA1A—polycystic ovary syndrome	0.000157	0.0349	CrCbGaD
Amitriptyline—ABCB1—adrenal gland—polycystic ovary syndrome	0.000155	0.00286	CbGeAlD
Amitriptyline—ABCB1—female gonad—polycystic ovary syndrome	0.000145	0.00267	CbGeAlD
Amitriptyline—ABCB1—vagina—polycystic ovary syndrome	0.000144	0.00265	CbGeAlD
Amitriptyline—ABCB1—endocrine gland—polycystic ovary syndrome	0.000135	0.00248	CbGeAlD
Amitriptyline—Desipramine—ADRB2—polycystic ovary syndrome	0.00011	0.0245	CrCbGaD
Amitriptyline—ADRA1D—Signaling Pathways—IGF1—polycystic ovary syndrome	2.8e-06	1.47e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—IGF1—polycystic ovary syndrome	2.8e-06	1.47e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—AKT2—polycystic ovary syndrome	2.8e-06	1.47e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—AKT2—polycystic ovary syndrome	2.8e-06	1.47e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	2.79e-06	1.47e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—GNAS—polycystic ovary syndrome	2.79e-06	1.47e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	2.77e-06	1.45e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	2.77e-06	1.45e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	2.75e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	2.74e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	2.74e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	2.73e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	2.73e-06	1.43e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.68e-06	1.41e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	2.68e-06	1.41e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—NCOR1—polycystic ovary syndrome	2.66e-06	1.4e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.66e-06	1.4e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.66e-06	1.4e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	2.65e-06	1.39e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—PPARG—polycystic ovary syndrome	2.63e-06	1.38e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	2.63e-06	1.38e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—IRS1—polycystic ovary syndrome	2.62e-06	1.38e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	2.61e-06	1.37e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IRS2—polycystic ovary syndrome	2.6e-06	1.37e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—POMC—polycystic ovary syndrome	2.6e-06	1.37e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	2.59e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	2.59e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	2.59e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	2.58e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	2.58e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—INS—polycystic ovary syndrome	2.58e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	2.56e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	2.56e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling by GPCR—IL6—polycystic ovary syndrome	2.56e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	2.55e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	2.55e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	2.54e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	2.54e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	2.54e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	2.54e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	2.53e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	2.52e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—POMC—polycystic ovary syndrome	2.52e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	2.52e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling by GPCR—IL6—polycystic ovary syndrome	2.52e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling by GPCR—IL6—polycystic ovary syndrome	2.52e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	2.51e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—INS—polycystic ovary syndrome	2.51e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	2.51e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	2.51e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	2.5e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—IL6—polycystic ovary syndrome	2.5e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling by GPCR—IL6—polycystic ovary syndrome	2.5e-06	1.31e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	2.5e-06	1.31e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.49e-06	1.31e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling by GPCR—IL6—polycystic ovary syndrome	2.45e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	2.45e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.44e-06	1.28e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.44e-06	1.28e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—IGF1—polycystic ovary syndrome	2.43e-06	1.28e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—AKT2—polycystic ovary syndrome	2.43e-06	1.27e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	2.42e-06	1.27e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	2.42e-06	1.27e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	2.42e-06	1.27e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	2.4e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—TH—polycystic ovary syndrome	2.39e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	2.39e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	2.38e-06	1.25e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling by GPCR—IL6—polycystic ovary syndrome	2.38e-06	1.25e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	2.37e-06	1.25e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—INS—polycystic ovary syndrome	2.37e-06	1.25e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	2.37e-06	1.24e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—MTHFR—polycystic ovary syndrome	2.35e-06	1.24e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	2.33e-06	1.23e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	2.33e-06	1.22e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	2.33e-06	1.22e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	2.32e-06	1.22e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	2.32e-06	1.22e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	2.32e-06	1.22e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.32e-06	1.22e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	2.31e-06	1.22e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	2.31e-06	1.21e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.3e-06	1.21e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	2.3e-06	1.21e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	2.29e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—IL6—polycystic ovary syndrome	2.28e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling by GPCR—IL6—polycystic ovary syndrome	2.28e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	2.28e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	2.27e-06	1.19e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	2.27e-06	1.19e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	2.27e-06	1.19e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	2.26e-06	1.19e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	2.26e-06	1.19e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	2.23e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	2.23e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	2.23e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	2.23e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—INS—polycystic ovary syndrome	2.22e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	2.22e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	2.21e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	2.21e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	2.21e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.21e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	2.2e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	2.19e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	2.19e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	2.19e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	2.19e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	2.18e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.18e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	2.18e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	2.18e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	2.18e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—INS—polycystic ovary syndrome	2.18e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	2.17e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—INS—polycystic ovary syndrome	2.17e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	2.17e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	2.17e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	2.17e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	2.16e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	2.16e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.15e-06	1.13e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	2.15e-06	1.13e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.15e-06	1.13e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	2.15e-06	1.13e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	2.14e-06	1.13e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling by GPCR—IL6—polycystic ovary syndrome	2.14e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling by GPCR—IL6—polycystic ovary syndrome	2.14e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	2.14e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	2.14e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.14e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	2.14e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	2.13e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	2.11e-06	1.11e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.11e-06	1.11e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.11e-06	1.11e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	2.1e-06	1.11e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	2.1e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	2.1e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	2.09e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.09e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	2.09e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	2.09e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	2.08e-06	1.09e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	2.07e-06	1.09e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	2.07e-06	1.09e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	2.07e-06	1.09e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	2.07e-06	1.09e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.06e-06	1.08e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.06e-06	1.08e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	2.06e-06	1.08e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.03e-06	1.07e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.03e-06	1.07e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2e-06	1.05e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2e-06	1.05e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	1.99e-06	1.05e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.99e-06	1.05e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.98e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	1.98e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.96e-06	1.03e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.96e-06	1.03e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	1.95e-06	1.03e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.94e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	1.94e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—IL6—polycystic ovary syndrome	1.94e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	1.93e-06	1.01e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	1.92e-06	1.01e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	1.92e-06	1.01e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	1.92e-06	1.01e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PPARG—polycystic ovary syndrome	1.91e-06	1e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	1.89e-06	9.94e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—INS—polycystic ovary syndrome	1.88e-06	9.89e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—POMC—polycystic ovary syndrome	1.88e-06	9.89e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—INS—polycystic ovary syndrome	1.87e-06	9.83e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	1.87e-06	9.8e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	1.86e-06	9.78e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—IL6—polycystic ovary syndrome	1.86e-06	9.75e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—TH—polycystic ovary syndrome	1.85e-06	9.71e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.85e-06	9.7e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.83e-06	9.61e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.83e-06	9.61e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.82e-06	9.57e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	1.8e-06	9.45e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	1.78e-06	9.34e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	1.76e-06	9.28e-06	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—IL6—polycystic ovary syndrome	1.72e-06	9.05e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	1.71e-06	9e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	1.69e-06	8.88e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	1.69e-06	8.88e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—INS—polycystic ovary syndrome	1.68e-06	8.83e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	1.67e-06	8.78e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—POMC—polycystic ovary syndrome	1.65e-06	8.66e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	1.65e-06	8.65e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—INS—polycystic ovary syndrome	1.64e-06	8.62e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.64e-06	8.61e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	1.61e-06	8.47e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.61e-06	8.45e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.6e-06	8.42e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	1.6e-06	8.4e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.59e-06	8.37e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.59e-06	8.33e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.58e-06	8.32e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	1.58e-06	8.29e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	1.57e-06	8.28e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	1.56e-06	8.21e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	1.55e-06	8.16e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—INS—polycystic ovary syndrome	1.54e-06	8.12e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	1.54e-06	8.09e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—INS—polycystic ovary syndrome	1.53e-06	8.05e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.52e-06	7.97e-06	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—IL6—polycystic ovary syndrome	1.51e-06	7.94e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.51e-06	7.93e-06	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—IL6—polycystic ovary syndrome	1.49e-06	7.82e-06	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—IL6—polycystic ovary syndrome	1.49e-06	7.82e-06	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—IL6—polycystic ovary syndrome	1.48e-06	7.76e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	1.47e-06	7.71e-06	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—IL6—polycystic ovary syndrome	1.45e-06	7.6e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.44e-06	7.55e-06	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—IL6—polycystic ovary syndrome	1.4e-06	7.38e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.4e-06	7.35e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.38e-06	7.23e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.37e-06	7.22e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.37e-06	7.2e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.36e-06	7.17e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.36e-06	7.16e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.35e-06	7.1e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.35e-06	7.08e-06	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—IL6—polycystic ovary syndrome	1.34e-06	7.07e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	1.33e-06	7.01e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	1.32e-06	6.92e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—INS—polycystic ovary syndrome	1.31e-06	6.88e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—IL6—polycystic ovary syndrome	1.28e-06	6.71e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.27e-06	6.67e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—IL6—polycystic ovary syndrome	1.26e-06	6.65e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—IL6—polycystic ovary syndrome	1.26e-06	6.65e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.25e-06	6.58e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	1.1e-06	5.79e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—IL6—polycystic ovary syndrome	1.1e-06	5.76e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	1.05e-06	5.52e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.03e-06	5.41e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.02e-06	5.34e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.01e-06	5.31e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	9.68e-07	5.09e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	9.52e-07	5e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	9.5e-07	4.99e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	9.47e-07	4.98e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	9.44e-07	4.96e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	9.35e-07	4.91e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	9.32e-07	4.9e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	8.66e-07	4.55e-06	CbGpPWpGaD
